Delivery Order SPE2DB22D1017-SPE2DB25FG7LB
Award Date
7/16/25
Potential Completion Date
7/17/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $11,131.76 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 15, 2025, with a completion date of July 16, 2025. The contract is not a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,120.74 fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $9,014.06 firm fixed price contract was awarded on July 16, 2025 with a completion date of July 17, 2025. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not a set-aside award. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA). The $9,738.66 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp on December 19, 2024, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,966.07. The contract is a firm fixed price delivery order, without a set-aside designation, and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 14, 2024 as a delivery order with a firm fixed price of $3,637.16 and a completion date of June 17, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $23,251.84, is a firm fixed-price delivery order with a completion date of May 22, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The $4,499.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 1, 2025, with a completion date of July 2, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The $33,592.30 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 16, 2025, with a completion date of June 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,108.48 and a period of performance through May 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...